Literature DB >> 16620973

Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.

Davide Rossi1, Francesca Cortini, Clara Deambrogi, Caterina Barbieri, Michaela Cerri, Silvia Franceschetti, Annarita Conconi, Daniela Capello, Gianluca Gaidano.   

Abstract

Idiopathic erythrocytosis (IE) is a primary erythrocytosis not fulfilling the criteria for polycythemia vera (PV) diagnosis. In order to verify the relationship between IE and PV, we screened JAK2V617F mutation in a consecutive series of 11 IE and, for comparison, in 15 PV. JAK2V617F mutation was screened by both cDNA sequencing and mutation specific PCR in both peripheral blood and bone marrow samples. All 11 IE tested negative for JAK2V617F mutation, which, conversely, occurred in 11/15 (73.3%) PV. Our results demonstrate that JAK2V617F is absent in IE and may represent a useful molecular marker for distinguishing IE from PV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620973     DOI: 10.1016/j.leukres.2006.02.027

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Determination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic scheme.

Authors:  Paul Roda; Ashley Ferrari; Xiaoqin Tang; Porat Erlich; Cindy Eisenhower; Megha D Patel; Elizabeth Ann Irvin-Barnwell
Journal:  Ann Hematol       Date:  2014-04-01       Impact factor: 3.673

2.  JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.

Authors:  Kentaro Yoshinaga; Naoki Mori; Yan-Hua Wang; Kaori Tomita; Masayuki Shiseki; Toshiko Motoji
Journal:  Int J Hematol       Date:  2008-06-06       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.